INSM logo

Insmed Incorporated (INSM) EBITDA

annual EBITDA:

-$818.79M-$158.62M(-24.03%)
December 31, 2024

Summary

  • As of today (May 21, 2025), INSM annual EBITDA is -$818.79 million, with the most recent change of -$158.62 million (-24.03%) on December 31, 2024.
  • During the last 3 years, INSM annual EBITDA has fallen by -$435.15 million (-113.42%).
  • INSM annual EBITDA is now -780.54% below its all-time high of $120.31 million, reached on December 31, 2009.

Performance

INSM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSMincome statement metrics

quarterly EBITDA:

-$232.78M-$21.04M(-9.94%)
March 31, 2025

Summary

  • As of today (May 21, 2025), INSM quarterly EBITDA is -$232.78 million, with the most recent change of -$21.04 million (-9.94%) on March 31, 2025.
  • Over the past year, INSM quarterly EBITDA has dropped by -$99.07 million (-74.10%).
  • INSM quarterly EBITDA is now -292.32% below its all-time high of $121.04 million, reached on March 31, 2009.

Performance

INSM quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSMincome statement metrics

TTM EBITDA:

-$917.87M-$99.07M(-12.10%)
March 31, 2025

Summary

  • As of today (May 21, 2025), INSM TTM EBITDA is -$917.87 million, with the most recent change of -$99.07 million (-12.10%) on March 31, 2025.
  • Over the past year, INSM TTM EBITDA has dropped by -$262.40 million (-40.03%).
  • INSM TTM EBITDA is now -862.89% below its all-time high of $120.31 million, reached on December 31, 2009.

Performance

INSM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSMincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

INSM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-24.0%-74.1%-40.0%
3 y3 years-113.4%-160.9%-133.5%
5 y5 years-277.2%-317.5%-342.2%

INSM EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-113.4%at low-160.9%+15.9%-141.3%at low
5 y5-year-277.2%at low-358.3%+15.9%-357.1%at low
alltimeall time-780.5%at low-292.3%+15.9%-862.9%at low

INSM EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$232.78M(+9.9%)
-$917.87M(+12.1%)
Dec 2024
-$818.79M(+24.0%)
-$211.74M(+7.8%)
-$818.79M(+6.4%)
Sep 2024
-
-$196.45M(-29.1%)
-$769.56M(+8.4%)
Jun 2024
-
-$276.89M(+107.1%)
-$709.62M(+8.3%)
Mar 2024
-
-$133.71M(-17.7%)
-$655.47M(-0.7%)
Dec 2023
-$660.18M(+47.6%)
-$162.50M(+19.0%)
-$660.18M(+3.3%)
Sep 2023
-
-$136.52M(-38.7%)
-$639.30M(+1.7%)
Jun 2023
-
-$222.74M(+60.9%)
-$628.91M(+26.7%)
Mar 2023
-
-$138.42M(-2.3%)
-$496.56M(+11.0%)
Dec 2022
-$447.37M(+16.6%)
-$141.63M(+12.3%)
-$447.37M(+10.2%)
Sep 2022
-
-$126.13M(+39.5%)
-$405.91M(+6.7%)
Jun 2022
-
-$90.39M(+1.3%)
-$380.33M(-3.3%)
Mar 2022
-
-$89.22M(-10.9%)
-$393.13M(+2.3%)
Dec 2021
-$383.65M(+53.2%)
-$100.18M(-0.4%)
-$384.45M(+2.5%)
Sep 2021
-
-$100.55M(-2.6%)
-$375.14M(+14.5%)
Jun 2021
-
-$103.19M(+28.1%)
-$327.56M(+19.0%)
Mar 2021
-
-$80.54M(-11.4%)
-$275.16M(+9.9%)
Dec 2020
-$250.37M(+15.3%)
-$90.87M(+71.6%)
-$250.37M(+24.0%)
Sep 2020
-
-$52.96M(+4.3%)
-$201.98M(+0.6%)
Jun 2020
-
-$50.79M(-8.9%)
-$200.80M(-3.3%)
Mar 2020
-
-$55.75M(+31.2%)
-$207.58M(-4.4%)
Dec 2019
-$217.07M(-26.5%)
-$42.48M(-18.0%)
-$217.07M(-15.7%)
Sep 2019
-
-$51.78M(-10.0%)
-$257.61M(-10.0%)
Jun 2019
-
-$57.56M(-11.8%)
-$286.31M(-3.9%)
Mar 2019
-
-$65.24M(-21.4%)
-$298.01M(+1.0%)
Dec 2018
-$295.18M(+59.7%)
-$83.02M(+3.1%)
-$295.18M(+7.0%)
Sep 2018
-
-$80.48M(+16.2%)
-$275.89M(+15.7%)
Jun 2018
-
-$69.27M(+11.0%)
-$238.55M(+12.7%)
Mar 2018
-
-$62.41M(-2.1%)
-$211.69M(+14.6%)
Dec 2017
-$184.87M(+8.6%)
-$63.73M(+47.7%)
-$184.67M(-1.3%)
Sep 2017
-
-$43.14M(+1.7%)
-$187.15M(+3.8%)
Jun 2017
-
-$42.41M(+19.8%)
-$180.31M(+4.1%)
Mar 2017
-
-$35.40M(-46.5%)
-$173.27M(+1.8%)
Dec 2016
-$170.24M(+47.7%)
-$66.21M(+82.4%)
-$170.24M(+25.3%)
Sep 2016
-
-$36.29M(+2.6%)
-$135.88M(+5.0%)
Jun 2016
-
-$35.37M(+9.3%)
-$129.36M(+6.5%)
Mar 2016
-
-$32.37M(+1.6%)
-$121.44M(+5.3%)
Dec 2015
-$115.28M(+33.9%)
-$31.85M(+7.0%)
-$115.28M(+8.6%)
Sep 2015
-
-$29.77M(+8.5%)
-$106.11M(+6.8%)
Jun 2015
-
-$27.44M(+4.7%)
-$99.38M(+5.3%)
Mar 2015
-
-$26.21M(+15.6%)
-$94.39M(+9.6%)
Dec 2014
-$86.09M(+58.8%)
-$22.68M(-1.5%)
-$86.09M(+9.2%)
Sep 2014
-
-$23.04M(+2.6%)
-$78.81M(+8.9%)
Jun 2014
-
-$22.45M(+25.3%)
-$72.40M(+24.8%)
Mar 2014
-
-$17.91M(+16.3%)
-$58.01M(+7.0%)
Dec 2013
-$54.20M(+35.3%)
-$15.40M(-7.4%)
-$54.20M(+1.2%)
Sep 2013
-
-$16.63M(+106.3%)
-$53.57M(+16.6%)
Jun 2013
-
-$8.06M(-42.8%)
-$45.96M(-3.1%)
Mar 2013
-
-$14.11M(-4.5%)
-$47.45M(+18.5%)
Dec 2012
-$40.05M
-$14.77M(+63.7%)
-$40.05M(+20.1%)
Sep 2012
-
-$9.02M(-5.6%)
-$33.34M(-43.3%)
Jun 2012
-
-$9.55M(+42.5%)
-$58.82M(-0.6%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$6.71M(-16.7%)
-$59.20M(-0.2%)
Dec 2011
-$59.31M(+857.7%)
-$8.05M(-76.7%)
-$59.31M(+4.1%)
Sep 2011
-
-$34.51M(+247.4%)
-$56.99M(+150.7%)
Jun 2011
-
-$9.94M(+45.8%)
-$22.74M(+72.6%)
Mar 2011
-
-$6.81M(+18.8%)
-$13.18M(+112.8%)
Dec 2010
-$6.19M(-105.1%)
-$5.74M(+2167.2%)
-$6.19M(+1569.3%)
Sep 2010
-
-$253.00K(-32.5%)
-$371.00K(+165.0%)
Jun 2010
-
-$375.00K(-319.3%)
-$140.00K(-74.5%)
Mar 2010
-
$171.00K(+98.8%)
-$550.00K(-100.5%)
Dec 2009
$120.31M(-1000.0%)
$86.00K(-490.9%)
$120.31M(+3.1%)
Sep 2009
-
-$22.00K(-97.2%)
$116.72M(+1.4%)
Jun 2009
-
-$785.00K(-100.6%)
$115.11M(+3.0%)
Mar 2009
-
$121.04M(-3550.3%)
$111.73M(-908.8%)
Dec 2008
-$13.37M(-33.3%)
-$3.51M(+114.6%)
-$13.81M(+2.3%)
Sep 2008
-
-$1.64M(-60.7%)
-$13.50M(-15.1%)
Jun 2008
-
-$4.17M(-7.6%)
-$15.90M(+11.8%)
Mar 2008
-
-$4.51M(+40.9%)
-$14.22M(-29.0%)
Dec 2007
-$20.03M(-60.7%)
-$3.20M(-20.7%)
-$20.03M(-47.0%)
Sep 2007
-
-$4.03M(+62.4%)
-$37.77M(-18.6%)
Jun 2007
-
-$2.48M(-75.9%)
-$46.37M(-12.7%)
Mar 2007
-
-$10.32M(-50.7%)
-$53.13M(+4.2%)
Dec 2006
-$51.00M(+250.9%)
-$20.93M(+65.7%)
-$51.00M(+62.0%)
Sep 2006
-
-$12.64M(+36.7%)
-$31.48M(+49.4%)
Jun 2006
-
-$9.24M(+12.8%)
-$21.07M(+20.9%)
Mar 2006
-
-$8.19M(+482.0%)
-$17.43M(+19.9%)
Dec 2005
-$14.54M(-46.9%)
-$1.41M(-36.8%)
-$14.54M(-23.5%)
Sep 2005
-
-$2.23M(-60.2%)
-$19.01M(-22.2%)
Jun 2005
-
-$5.60M(+5.8%)
-$24.42M(-12.4%)
Mar 2005
-
-$5.30M(-9.9%)
-$27.87M(+1.7%)
Dec 2004
-$27.39M(+161.1%)
-$5.88M(-23.0%)
-$27.39M(+14.1%)
Sep 2004
-
-$7.64M(-15.6%)
-$24.00M(+27.6%)
Jun 2004
-
-$9.05M(+87.7%)
-$18.80M(+44.2%)
Mar 2004
-
-$4.82M(+93.7%)
-$13.04M(+24.3%)
Dec 2003
-$10.49M(-69.3%)
-$2.49M(+1.8%)
-$10.49M(-60.6%)
Sep 2003
-
-$2.44M(-25.6%)
-$26.60M(+1.0%)
Jun 2003
-
-$3.29M(+44.6%)
-$26.34M(-12.8%)
Mar 2003
-
-$2.27M(-87.8%)
-$30.23M(-11.5%)
Dec 2002
-$34.15M(-11.6%)
-$18.60M(+750.6%)
-$34.15M(+34.9%)
Sep 2002
-
-$2.19M(-69.5%)
-$25.32M(-20.2%)
Jun 2002
-
-$7.17M(+15.7%)
-$31.74M(-6.2%)
Mar 2002
-
-$6.19M(-36.7%)
-$33.85M(-12.4%)
Dec 2001
-$38.64M(+27.5%)
-$9.78M(+13.5%)
-$38.64M(-398.4%)
Sep 2001
-
-$8.61M(-7.1%)
$12.95M(-20.7%)
Jun 2001
-
-$9.27M(-15.7%)
$16.34M(-154.6%)
Mar 2001
-
-$10.99M(-126.3%)
-$29.90M(-1.3%)
Dec 2000
-$30.31M(+276.9%)
$41.82M(-900.2%)
-$30.31M(-58.0%)
Sep 2000
-
-$5.23M(-90.6%)
-$72.13M(+7.8%)
Jun 2000
-
-$55.51M(+387.0%)
-$66.90M(+412.5%)
Mar 2000
-
-$11.40M(+587.8%)
-$13.05M(+305.7%)
Dec 1999
-$8.04M
-
-
Jun 1999
-
-$1.66M(+6.1%)
-$3.22M(+106.1%)
Mar 1999
-
-$1.56M
-$1.56M

FAQ

  • What is Insmed Incorporated annual EBITDA?
  • What is the all time high annual EBITDA for Insmed Incorporated?
  • What is Insmed Incorporated annual EBITDA year-on-year change?
  • What is Insmed Incorporated quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Insmed Incorporated?
  • What is Insmed Incorporated quarterly EBITDA year-on-year change?
  • What is Insmed Incorporated TTM EBITDA?
  • What is the all time high TTM EBITDA for Insmed Incorporated?
  • What is Insmed Incorporated TTM EBITDA year-on-year change?

What is Insmed Incorporated annual EBITDA?

The current annual EBITDA of INSM is -$818.79M

What is the all time high annual EBITDA for Insmed Incorporated?

Insmed Incorporated all-time high annual EBITDA is $120.31M

What is Insmed Incorporated annual EBITDA year-on-year change?

Over the past year, INSM annual EBITDA has changed by -$158.62M (-24.03%)

What is Insmed Incorporated quarterly EBITDA?

The current quarterly EBITDA of INSM is -$232.78M

What is the all time high quarterly EBITDA for Insmed Incorporated?

Insmed Incorporated all-time high quarterly EBITDA is $121.04M

What is Insmed Incorporated quarterly EBITDA year-on-year change?

Over the past year, INSM quarterly EBITDA has changed by -$99.07M (-74.10%)

What is Insmed Incorporated TTM EBITDA?

The current TTM EBITDA of INSM is -$917.87M

What is the all time high TTM EBITDA for Insmed Incorporated?

Insmed Incorporated all-time high TTM EBITDA is $120.31M

What is Insmed Incorporated TTM EBITDA year-on-year change?

Over the past year, INSM TTM EBITDA has changed by -$262.40M (-40.03%)
On this page